Plasma EBV DNA

DIAGNOSTIC_TEST2 trials

Sponsors

Taichung Veterans General Hospital, Sun Yat-sen University

Conditions

Nasopharyngeal Carcinoma

Unknown Phase

Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma

Taichung Veterans General HospitalNasopharyngeal Carcinoma

Start: 2017-04-01End: 2019-01-16Target: 200Updated: 2017-03-22

Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2019-05-09End: 2024-05-01Target: 1000Updated: 2023-06-18

Related Papers

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

2026-03-11

Establishment and validation of a dynamic prognostic model using serial circulating tumor DNA (ctDNA) for endemic EBV-related nasopharyngeal carcinoma (NPC): A secondary analysis of EP-SEASON.

Journal of Clinical Oncology2025-05-28

Longitudinal tracing of on-treatment plasma Epstein-Barr virus DNA as a biomarker for real-time dynamic risk monitoring in patients with nasopharyngeal carcinoma: The EP-SEASON study.

Journal of Clinical Oncology2024-08-10

Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study

Cancer Cell2024-07-2548 citations